NMOS ARCHITECTURE INVOLVING EPITAXIALLY-GROWN IN-SITU N-TYPE-DOPED EMBEDDED eSiGe:C SOURCE/DRAIN TARGETING
    102.
    发明申请
    NMOS ARCHITECTURE INVOLVING EPITAXIALLY-GROWN IN-SITU N-TYPE-DOPED EMBEDDED eSiGe:C SOURCE/DRAIN TARGETING 有权
    涉及外延生长的N型掺杂嵌入式的NMOS结构eSiGe:C源/漏极区

    公开(公告)号:US20110133189A1

    公开(公告)日:2011-06-09

    申请号:US12632351

    申请日:2009-12-07

    Applicant: Bin Yang Bo Bai

    Inventor: Bin Yang Bo Bai

    Abstract: An NMOS transistor is formed with improved manufacturability. An embodiment includes forming N-type doped embedded silicon germanium containing carbon (eSiGe:C) in source/drain regions of a substrate, and amorphizing the eSiGe:C. The use of eSiGe:C provides a reduction in extension silicon and dopant loss, improved morphology, increased wafer throughput, improved short channel control, and reduced silicide to source/drain contact resistance.

    Abstract translation: 形成具有改进的可制造性的NMOS晶体管。 实施例包括在衬底的源极/漏极区域中形成含有N型掺杂的含硅锗(eSiGe:C),并使eSiGe:C非晶化。 eSiGe:C的使用提供了延长硅和掺杂剂损耗的减少,改进的形态,增加的晶片产量,改进的短沟道控制以及降低的硅化物到源/漏接触电阻。

    Lignin blockers and uses thereof
    103.
    发明授权
    Lignin blockers and uses thereof 有权
    木质素阻滞剂及其用途

    公开(公告)号:US07875444B2

    公开(公告)日:2011-01-25

    申请号:US11229817

    申请日:2005-09-19

    CPC classification number: C12P7/10 C12P7/08 C12P19/02 Y02E50/16 Y02E50/17

    Abstract: Disclosed is a method for converting cellulose in a lignocellulosic biomass. The method provides for a lignin-blocking polypeptide and/or protein treatment of high lignin solids. The treatment enhances cellulase availability in cellulose conversion and allows for the determination of optimized pretreatment conditions. Additionally, ethanol yields from a Simultaneous Saccharification and Fermentation process are improved 5-25% by treatment with a lignin-blocking polypeptide and/or protein. Thus, a more efficient and economical method of processing lignin containing biomass materials utilizes a polypeptide/protein treatment step that effectively blocks lignin binding of cellulase.

    Abstract translation: 公开了一种在木质纤维素生物质中转化纤维素的方法。 该方法提供高木质素固体的木质素阻断多肽和/或蛋白质处理。 该处理增强了纤维素转化中的纤维素酶可用性,并且允许确定优化的预处理条件。 此外,通过用木质素阻断多肽和/或蛋白质处理,来自同时糖化和发酵过程的乙醇产率提高了5-25%。 因此,处理含木质素的生物质材料的更有效和经济的方法利用有效阻断木质素结合纤维素酶的多肽/蛋白质处理步骤。

    Multimerization of HIV-1 Vif protein as a therapeutic target
    107.
    发明授权
    Multimerization of HIV-1 Vif protein as a therapeutic target 有权
    HIV-1 Vif蛋白多聚化作为治疗靶点

    公开(公告)号:US07498138B2

    公开(公告)日:2009-03-03

    申请号:US11809953

    申请日:2007-06-04

    CPC classification number: C07K14/005 A61K38/00 C12N2740/16322 Y10S530/826

    Abstract: The HIV-1 protein Vif comprises a multimerization domain that allows Vif-Vif interaction and Vif multimerization, which is important for Vif function in the HIV-1 life-cycle. A method for screening for an antagonist of Vif comprises contacting the multimerization domain of Vif with a test compound that specifically binds the multimerization domain. Antagonists identified by the screening assay inhibit Vif multimerization. The antagonists inhibit essential functions of Vif and accordingly are useful as inhibitors of HIV-1 replication.

    Abstract translation: HIV-1蛋白Vif包含允许Vif-Vif相互作用和Vif多聚化的多聚化结构域,这对HIV-1生命周期中的Vif功能是重要的。 用于筛选Vif拮抗剂的方法包括使Vif的多聚化结构域与特异性结合多聚化结构域的测试化合物接触。 通过筛选测定鉴定的拮抗剂抑制Vif多聚化。 拮抗剂抑制Vif的基本功能,因此可用作HIV-1复制的抑制剂。

Patent Agency Ranking